These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A guide to improve your causal inferences from observational data. Raymaekers K; Luyckx K; Moons P Eur J Cardiovasc Nurs; 2020 Dec; 19(8):757-762. PubMed ID: 33040589 [TBL] [Abstract][Full Text] [Related]
7. Targeted Maximum Likelihood Estimation for Causal Inference in Observational Studies. Schuler MS; Rose S Am J Epidemiol; 2017 Jan; 185(1):65-73. PubMed ID: 27941068 [TBL] [Abstract][Full Text] [Related]
8. Observational studies - should we simply ignore them in assessing transfusion outcomes? Trentino K; Farmer S; Gross I; Shander A; Isbister J BMC Anesthesiol; 2016 Oct; 16(1):96. PubMed ID: 27741940 [TBL] [Abstract][Full Text] [Related]
9. The architecture of clinical research (From the "Biostatistics and Epidemiology Lecture Series, Part 1"). Stoller JK Cleve Clin J Med; 2017 Sep; 84(9 Suppl 2):e2-e9. PubMed ID: 28937357 [No Abstract] [Full Text] [Related]
10. Causal Methods for Observational Research: A Primer. Almasi-Hashiani A; Nedjat S; Mansournia MA Arch Iran Med; 2018 Apr; 21(4):164-169. PubMed ID: 29693407 [TBL] [Abstract][Full Text] [Related]
11. Reporting of Limitations of Observational Research. Wang MT; Bolland MJ; Grey A JAMA Intern Med; 2015 Sep; 175(9):1571-2. PubMed ID: 26053740 [No Abstract] [Full Text] [Related]
12. A new risk of bias checklist applicable to randomized trials, observational studies, and systematic reviews was developed and validated to be used for systematic reviews focusing on drug adverse events. Faillie JL; Ferrer P; Gouverneur A; Driot D; Berkemeyer S; Vidal X; Martínez-Zapata MJ; Huerta C; Castells X; Rottenkolber M; Schmiedl S; Sabaté M; Ballarín E; Ibáñez L J Clin Epidemiol; 2017 Jun; 86():168-175. PubMed ID: 28487158 [TBL] [Abstract][Full Text] [Related]
13. Cautionary tales in the interpretation of observational studies of effects of clinical interventions. Scott IA; Attia J Intern Med J; 2017 Feb; 47(2):144-157. PubMed ID: 27345967 [TBL] [Abstract][Full Text] [Related]
14. Assessing strength of evidence for regulatory decision making in licensing: What proof do we need for observational studies of effectiveness? Slattery J; Kurz X Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1336-1340. PubMed ID: 32301230 [TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. Hannan EL JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302 [TBL] [Abstract][Full Text] [Related]
17. Improving confidence in observational studies : should statistical analysis plans be made publicly available? Onukwugha E Pharmacoeconomics; 2013 Mar; 31(3):177-9. PubMed ID: 23338964 [No Abstract] [Full Text] [Related]
18. Confounding, causality, and confusion: the role of intermediate variables in interpreting observational studies in obstetrics. Ananth CV; Schisterman EF Am J Obstet Gynecol; 2017 Aug; 217(2):167-175. PubMed ID: 28427805 [TBL] [Abstract][Full Text] [Related]
19. Sample Size Estimation in Clinical Research: From Randomized Controlled Trials to Observational Studies. Wang X; Ji X Chest; 2020 Jul; 158(1S):S12-S20. PubMed ID: 32658647 [TBL] [Abstract][Full Text] [Related]
20. Sample size calculations in randomized trials: common pitfalls. Brasher PM; Brant RF Can J Anaesth; 2007 Feb; 54(2):103-6. PubMed ID: 17272248 [No Abstract] [Full Text] [Related] [Next] [New Search]